Aaron D Fobian

Dr. Aaron D Fobian

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
LRLeeba Rezaie
Leeba Rezaie
AFAaron D Fobian
Aaron D Fobian
WMWilliam Vaughn McCall
William Vaughn McCall
Habibolah KhazaieHabibolah Khazaie
Habibolah Khazaie


1 January 2019 in Journal of Psychiatry and Neuroscience
Verified
Journal Article
Closed access
AFAaron D Fobian
Aaron D Fobian
LELindsey Elliott
Lindsey Elliott
Functional neurological symptom disorder (FNSD) is characterized by neurological symptoms that are unexplained by other traditional neurological or medical conditions. Both physicians and patients have limited understanding of FNSD, which is often explained as a physical manifestation of psychological distress. Recently, diagnostic criteria have shifted from requiring a preceding stressor to relying on positive symptoms. Given this shift, we have provided a review of the etiology of FNSD. Predisposing factors include trauma or psychiatric symptoms, somatic symptoms, illness exposure, symptom monitoring and neurobiological factors. Neurobiological research has indicated that patients with FNSD have a decreased sense of agency and abnormal attentional focus on the affected area, both of which are modulated by beliefs and expectations about illness. Sick role and secondary gain may reinforce and maintain FNSD. The integrated etiological summary model combines research from various fields and other recent etiological models to represent the current understanding of FNSD etiology. It discusses a potential causal mechanism and informs future research and treatment.

1 January 2016 in Journal of Developmental & Behavioral Pediatrics
Verified
Journal Article
Closed access
AFAaron D Fobian
Aaron D Fobian
KAKristin Avis
Kristin Avis
DSDavid C. Schwebel
David C. Schwebel
Objective: In 2010, American youth aged 8 to 18 spent an average of 7.5 hours daily using entertainment media, an increase of more than an hour compared with 2005. Increase in media use is associated with multiple negative outcomes, including decreased sleep time and increased tiredness, but little research has examined whether media use is associated with poorer sleep efficiency when the individual is actually asleep. Methods: This study assessed relations between adolescent media use and sleep efficiency. Fifty-five adolescents (mean age = 14.89 years; SD = 0.62; 53% African-American and 47% white) completed self-report measures concerning their media use. Sleep quality was measured by actigraphy for 1 week, and both sleep offset and sleep efficiency were extracted from actigraphy data. Results: Sleep efficiency was negatively correlated to daily time spent text messaging (r(52) = −0.29; p < .05), media use after bed (r(52) = −0.32; p < .05), and number of nighttime awakenings by mobile phones (r(52) = −0.33; p < .05). Decreased sleep efficiency was related to sleeping later in the morning, presumably to make up for lost sleep at night (r(52) = −0.33; p < .05). In a regression model, media use accounted for 30% of the variance in sleep efficiency (adjusted R2 = 0.30; F(6,44) = 3.74; p < .01). Conclusion: Media use after bed, awakenings by a mobile phone at night, and sleep offset associated with adolescents' sleep efficiency. Results support the incorporation of media use habits into adolescent sleep health education and sleep dysfunction interventions. Parental education about the effects of media use on sleep could also mitigate negative effects.

3 August 2020 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
AFAaron D Fobian
Aaron D Fobian
DLDustin M. Long
Dustin M. Long
JSJerzy P. Szaflarski
Jerzy P. Szaflarski
Objective: Our aim was to conduct a pilot randomized controlled trial of a novel cognitive behaviorally based intervention for pediatric PNES called Retraining and Control Therapy (ReACT).Methods: Participants were randomized to receive either eight sessions of ReACT or supportive therapy, and participants completed follow‐up visits at 7‐ and 60‐days posttreatment. The primary outcome measure was PNES frequency at 7‐days posttreatment. Eligibility criteria included children with video‐EEG confirmed PNES and participant/parent or guardian willingness to participate in treatment. Exclusion criteria included substance use, psychosis, and severe intellectual disability. Forty‐two patients were assessed for eligibility and 32 were randomized. ReACT aimed to retrain classically conditioned, involuntary PNES by targeting catastrophic symptom expectations and a low sense of control over symptoms using principles of habit reversal. Supportive therapy was based on the assumption that relief from stress or problems can be achieved by discussion with a therapist.Results: Twenty‐nine participants (Mage = 15.1 years, SDage = 2.5; 72.2% female; 57.1% Caucasian, 28.6% African American) completed 7‐days postprocedures. For PNES frequency, the Wilcoxon Rank Sum test statistic was 273.5 yielding a normal approximation of Z = 4.725 (P < 0.0001), indicating a significant improvement in PNES frequency for ReACT at 7‐days posttreatment compared to supportive therapy. Participants with PNES in the 7‐days posttreatment were removed from the study for additional treatment, resulting in no 60‐day follow‐up data for supportive therapy.Interpretation: ReACT resulted in significantly greater PNES reduction than supportive therapy, with 100% of patients experiencing no PNES in 7 days after ReACT. Additionally, 82% remained PNES‐free for 60 days after ReACT.

1 May 2018 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
AFAaron D Fobian
Aaron D Fobian
LELindsey Elliott
Lindsey Elliott
TLTinnie Louie
Tinnie Louie